Back to Search
KELLY MILLER, M.D.
M.D.
Anesthesiology Physician
NPI: 1891019337IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
01072633A(IN)
Education
INDIANA UNIVERSITY SCHOOL OF MEDICINE
Class of 2010
Research & Publications (20)
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer.
PMID 18160686·N Engl J Med·2007
3-trial
A physiologic imaging pilot study of breast cancer treated with AZD2171.
PMID 16397053·Clin Cancer Res·2006
7-preclinical
A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer.
PMID 15867237·Clin Cancer Res·2005
3-trial
Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.
PMID 15681523·J Clin Oncol·2005
3-trial
Randomized phase II trial of the anti-angiogenic potential of doxorubicin and docetaxel; primary chemotherapy as Biomarker Discovery Laboratory.
PMID 15692762·Breast Cancer Res Treat·2005
3-trial
Breast cancer: the role of angiogenesis and antiangiogenic therapy.
PMID 15474336·Hematol Oncol Clin North Am·2004
6-review
A phase II study of 9-nitro-camptothecin in patients with previously treated metastatic breast cancer.
PMID 14707496·Invest New Drugs·2004
3-trial
Recent translational research: antiangiogenic therapy for breast cancer - where do we stand?
PMID 15084233·Breast Cancer Res·2004
4-observational
A randomized phase II feasibility trial of BMS-275291 in patients with early stage breast cancer.
PMID 15041714·Clin Cancer Res·2004
3-trial
The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era.
PMID 12488288·Ann Oncol·2003
6-review
E2100: a phase III trial of paclitaxel versus paclitaxel/bevacizumab for metastatic breast cancer.
PMID 12636887·Clin Breast Cancer·2003
8-other
Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival.
PMID 12853349·Ann Oncol·2003
8-other
Issues and challenges for antiangiogenic therapies.
PMID 12353823·Breast Cancer Res Treat·2002
6-review
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer.
PMID 12181245·Ann Oncol·2002
3-trial
Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.
PMID 11252888·Oncology (Williston Park)·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 8450 NORTHWEST BLVD
INDIANAPOLIS, IN 46278 - Phone
- (317) 802-2000
Quick Facts
- NPI
- 1891019337
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile